Latest KFF Health News Content

Latest KFF Health News Stories

Medicare Delays Plans For New Star Ratings On Hospitals After Congressional Pressure

KFF Health News Original

The “overall hospital quality” rating is designed to help consumers who are sometimes confused by the variety of quality measures that the government already provides. But members of Congress had asked for the delay because of concerns that the methodology for the stars was not accurate.

At Teaching Hospitals, Aggressive Screening May Lead To Medicare Penalties

KFF Health News Original

Nearly half of academic medical centers will be penalized by the government this year for high rates of infections and other avoidable complications, but the hospitals say it shows they screen better for problems.

Texas Asks Federal Officials To Renew Medicaid Funds For Hospitals

Morning Briefing

The funding, which helps hospitals cover uncompensated care for patients without insurance, is supposed to be reduced under the health law because Medicaid expansion would cover many of those patients. But Texas did not expand its Medicaid program. Also, a look at how the Labor Department’s new overtime rule is affecting health care providers, and North Carolina officials seek residents’ views on changes to Medicaid there.

‘Smokeless Doesn’t Mean Harmless’: FDA Launches $36M Campaign Against Chewing Tobacco

Morning Briefing

The Food and Drug Administration’s Mitch Zeller, director of the agency’s tobacco program, says smokeless tobacco is culturally ingrained in rural areas as a rite of passage, and that many of those young people don’t fully understand the health effects of the habit.

Opioid Epidemic Casts Shadow On Marijuana Legalization In New England

Morning Briefing

Marijuana advocates have turned their attention to the fairly liberal enclave of northeastern states, but the region has been particularly hard hit by the opioid crisis making residents and lawmakers skittish on the topic. Meanwhile, Maine regulators are considering marijuana as an alternative to prescription pain killers, and a Minnesota senator is trying to increase access to naloxone, an anti-overdose drug.

Life Expectancy Dips For White Women: Statistical Blip Or ‘Harbinger Of Things To Come’?

Morning Briefing

Recent reports show an increase in suicides, overdoses and unintentional poisonings — which is mainly alcohol and drug poisoning — but researchers say they need more data in years to come to determine if the drop is significant.

Johnson & Johnson’s Prescription Drug Revenue Boosts Quarterly Earnings

Morning Briefing

In other pharmaceutical news, a health plan shifts its hepatitis C stance amid outcry that the expensive drug is being covered only when the disease becomes life-threatening, Express Scripts files off a volley of its own in Anthem contract dispute, and the Food and Drug Administration’s new chief says the agency shouldn’t distance itself too far from the industry it regulates.

Theranos’ Fate Could Hinge On Thin Line Between Rosy Projections And False Promotion

Morning Briefing

At worst, if investigators find evidence of hype that crosses the line with the blood-testing startup, its executives could face jail time. Meanwhile, Theranos board member David Boies says he has confidence in CEO Elizabeth Holmes following news of investigations into the company.

Medicare Proposal Would Drop Cuts To Hospitals Based On Two-Midnight Inpatient Rule

Morning Briefing

The wide-ranging proposed rule for hospital payments seeks to mute industry criticism of how federal officials handle reimbursements and classifications for inpatients, as well as overpayments and bundled services.